These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11317017)

  • 1. Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
    Dede F; Ajoedi ND; Ansari SM; Jana S; Heiba SI; Abdel-Dayem HM
    Clin Nucl Med; 2001 May; 26(5):396-9. PubMed ID: 11317017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
    Sarlis NJ; Gourgiotis L; Guthrie LC; Galen B; Skarulis MC; Shawker TH; Patronas NJ; Reynolds JC
    Clin Nucl Med; 2003 Mar; 28(3):208-17. PubMed ID: 12592128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
    Lassen U; Daugaard G; Eigtved A; Damgaard K; Friberg L
    Eur J Cancer; 1999 Jul; 35(7):1076-82. PubMed ID: 10533451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission imaging of head and neck cancer, including thyroid carcinoma.
    Schöder H; Yeung HW
    Semin Nucl Med; 2004 Jul; 34(3):180-97. PubMed ID: 15202100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
    Jeong HJ; Chung JK; Kim YK; Kim CY; Kim DG; Jeong JM; Lee DS; Jung HW; Lee MC
    J Nucl Med; 2002 Nov; 43(11):1432-7. PubMed ID: 12411544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine leiomyosarcoma metastatic to thyroid shown by
    Gauthé M; Testart Dardel N; Nascimento C; Trassard M; Banal A; Alberini JL
    Rev Esp Med Nucl Imagen Mol; 2017; 36(2):113-115. PubMed ID: 27777040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
    J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors].
    Shinohara M; Tomita M; Ohira S; Nishimura A
    Hokkaido Igaku Zasshi; 1999 May; 74(3):249-56. PubMed ID: 10422568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary squamous cell carcinoma of the thyroid. Initial assessment and follow-up using
    Caballero Gullón L; Carmona González E; Martínez Estévez A; Gómez Camarero MP; Corral JJ; Borrego Dorado I
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):257-259. PubMed ID: 28219646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F-FDG whole-body positron-emission tomography (PET) in patients with unknown primary tumors].
    Matheja P; Schober O
    Strahlenther Onkol; 2000 Mar; 176(3):151-2. PubMed ID: 10742838
    [No Abstract]   [Full Text] [Related]  

  • 12. [FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
    Szakáll S; Bajzik G; Repa I; Miklovicz T; Dabasi G; Sinkovics I; Esik O
    Orv Hetil; 2002 May; 143(21 Suppl 3):1280-3. PubMed ID: 12077916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of unknown occult primary tumors using positron emission tomography.
    Kole AC; Nieweg OE; Pruim J; Hoekstra HJ; Koops HS; Roodenburg JL; Vaalburg W; Vermey A
    Cancer; 1998 Mar; 82(6):1160-6. PubMed ID: 9506364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
    Frilling A; Tecklenborg K; Görges R; Weber F; Clausen M; Broelsch EC
    Ann Surg; 2001 Dec; 234(6):804-11. PubMed ID: 11729387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic undifferentiated spindle cell sarcoma of the thyroid gland evaluated by 18F-FDG PET/CT.
    Treglia G; Bongiovanni M; Paone G; Ceriani L; Giovanella L
    Clin Nucl Med; 2015 Mar; 40(3):e208-10. PubMed ID: 25140545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.
    Muros MA; Llamas-Elvira JM; Ramírez-Navarro A; Gómez MJ; Rodríguez-Fernández A; Muros T; López de la Torre M; Becerra A; Carreras JL
    Am J Surg; 2000 Jun; 179(6):457-61. PubMed ID: 11004330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
    Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
    Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography: useful in detecting metastatic cancer of unknown primary site.
    Ruiz-Ruiz FJ; Saenz-Abad D; Hualde-Enguita AM; Morales-Rull JL
    Singapore Med J; 2005 Jun; 46(6):302-3. PubMed ID: 15902359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.